Global CyberKnife Market Size, Trends & Growth Opportunity, By Application (Tumor, Cancer, Vascular Malformation, Air-displacement Plethysmography, and Others), By End-user (Hospitals, Outpatient facilities, Research and Manufacturing), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global CyberKnife Market.
The Global Cyberknife Market was valued at USD 536.36 million in 2021 which is expected to reach USD 1,587.9 million by 2027 at a CAGR of 19.7% from 2022-2027.
Radiation therapy equipment called the CyberKnife system is made by Accuray Incorporated. The CyberKnife system combines real-time AI-driven target tracking and treatment delivery to deliver high-energy x-rays or photons used in radiation therapy. It is the only radiation delivery system in the world with a linear accelerator (linac) directly mounted on a robot.
Market Drivers
The growing prevalence of cancer, recent product launches, and a rising preference for non-invasive & minimally invasive procedures over surgery are driving the cyberKnife market forward. The increasing prevalence of cancer is the most important factor driving the market growth.
Market Segmentation
The global cyberknife market is segmented into application, end-user, and region.
By application, the market is segmented into tumor, cancer, vascular malformation, air-displacement plethysmography, and others. Further, by end-user, the market is segmented into hospitals, outpatient facilities, research, and manufacturing.
Regional Analysis
The global cyberknife market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America held the largest revenue share in the cyberKnife market in 2022. Factors such as rising chronic disease prevalence, a rapid shift towards painless and non-invasive surgeries, and rising demand for less time-consuming treatments are driving the growth of the cyberKnife market in this region.
According to the American Society for Radiation Oncology, the number of radiation facilities in the United States increased from 1,987 in 2005 to 2,332 in 2020, representing a 17.0% increase.
Recent Development
In June 2020, Accuray Incorporated introduced the CyberKnife S7 system. It is the next-generation cyberKnife platform, a robotic, non-invasive radiation therapy device used to treat cancerous and benign tumors throughout the body, as well as neurologic disorders. The product is designed to meet the demands of clinicians for operational efficiency.
Key Players
Various key players are listed in this report such as Accuray Incorporated, Varian Medical Systems, Koninklijke Philips.
Market Taxonomy
By Application
• Tumor
• Cancer
• Vascular malformation
• Others
By End-user
• Hospitals
• Outpatient facilities
• Research and Manufacturing
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global CyberKnife Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global CyberKnife Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global CyberKnife Market, By Application
5.1 Y-o-Y Growth Comparison, By Application
5.2 Global CyberKnife Market Share Analysis, By Application
5.3 Global CyberKnife Market Size and Forecast, By Application
5.3.1 Tumor
5.3.2 Cancer
5.3.3 Vascular malformation
5.3.4 Others
6 Global CyberKnife Market, By End-user
6.1 Y-o-Y Growth Comparison, By End-user
6.2 Global CyberKnife Market Share Analysis, By End-user
6.3 Global CyberKnife Market Size and Forecast, By End-user
6.3.1 Hospitals
6.3.2 Outpatient facilities
6.3.3 Research and Manufacturing
7 Global CyberKnife Market, By Region
7.1 Global CyberKnife Market Share Analysis, By Region
7.2 Global CyberKnife Market Share Analysis, By Region
7.3 Global CyberKnife Market Size and Forecast, By Region
8 North America CyberKnife Market Analysis and Forecast (2022-2027)
8.1 Introduction
8.2 North America CyberKnife Market Share Analysis, By Application
8.3 North America CyberKnife Market Size and Forecast, By End-user
8.4 North America CyberKnife Market Size and Forecast, By Country
8.5.1 U.S.
8.6.2 Canada
9.7.3 Mexico
9 Europe CyberKnife Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 Europe CyberKnife Market Share Analysis, By Application
9.3 Europe CyberKnife Market Size and Forecast, By End-user
9.4 Europe CyberKnife Market Size and Forecast, By Country
9.5.1 Germany
9.6.2 France
9.7.3 UK
9.8.4. Rest of Europe
10 Asia Pacific CyberKnife Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Asia Pacific CyberKnife Market Share Analysis, By Application
10.3 Asia Pacific CyberKnife Market Size and Forecast, By End-user
10.4 Asia Pacific CyberKnife Market Size and Forecast, By Country
10.5.1 China
10.6.2 Japan
10.7.3 India
10.8.4. Rest of Asia Pacific
11 Latin America CyberKnife Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Latin America CyberKnife Market Share Analysis, By Application
11.3 Latin America CyberKnife Market Size and Forecast, By End-user
11.4 Latin America CyberKnife Market Size and Forecast, Country
11.5.1. Brazil
11.6.2. Rest of Latin America
12 Middle East CyberKnife Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Middle East CyberKnife Market Share Analysis, By Application
12.3 Middle East CyberKnife Market Size and Forecast, By End-user
12.4 Middle East CyberKnife Market Size and Forecast, By Country
12.5.1. Saudi Arabia
12.6.2. UAE
12.7.3. Egypt
12.8.4. Kuwait
12.9.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Accuray Incorporated
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Varian Medical Systems
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Koninklijke Philips
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
